Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation

Sci Rep. 2020 Aug 6;10(1):13274. doi: 10.1038/s41598-020-70203-x.

Abstract

Although recent studies indicate the involvement of monocytes in accelerating the lesion formation of neuromyelitis optica spectrum disorder (NMOSD), the precise mechanism of the innate immune system activation remains elusive. Thus, in this study, we aimed to clarify the mechanisms of NMOSD pathogenesis from the viewpoint of innate immunity activation. We established anti-AQP4 recombinant autoantibodies (Ab) from plasmablasts in NMOSD patient's CSF. Human astrocytes treated with anti-AQP4 Ab produced a significant amount of CCL2 and contributed to the efficient recruitment of monocytes. Moreover, mitochondrial DNA (mtDNA), which activated monocytes via Toll-like receptor 9 (TLR9), was released from astrocytes treated with anti-AQP4 Ab. MtDNA further enhanced CCL2 production by monocytes, and it was demonstrated that mtDNA concentration correlated with the efficiency of monocyte recruitment in the CSF of NMOSD patients. In conclusion, these observations highlight that mtDNA which was released from astrocytes damaged by anti-AQP4 Ab has a central role in establishing the inflammatory loop of monocyte recruitment and activation via an innate immunity pathway.

MeSH terms

  • Adult
  • Aged
  • Antibodies / pharmacology
  • Aquaporin 4 / immunology*
  • Astrocytes / drug effects
  • Astrocytes / immunology
  • Chemokine CCL2 / metabolism
  • DNA, Mitochondrial / genetics*
  • Female
  • HEK293 Cells
  • Humans
  • Immunity, Innate
  • Middle Aged
  • Mitochondria / genetics*
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Neuromyelitis Optica / genetics*
  • Neuromyelitis Optica / immunology
  • Toll-Like Receptor 9 / metabolism

Substances

  • AQP4 protein, human
  • Antibodies
  • Aquaporin 4
  • CCL2 protein, human
  • Chemokine CCL2
  • DNA, Mitochondrial
  • TLR9 protein, human
  • Toll-Like Receptor 9